Development of Therapeutics for Biodefense

Information

• Research Project
• 8355059

• ApplicationId

  8355059

• Core Project Number

  272201100029C-0-9999-1

• Full Project Number

  272201100029C-0-9999-1

• Serial Number

  0

• FOA Number

• Sub Project Id

• Project Start Date

  9/27/2011 - 14 years ago

• Project End Date

  3/30/2014 - 11 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2011

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• Enanta Pharmaceuticals, Inc.

This contract supports the advanced development of promising biodefense therapeutic candidates/products with broad spectrum activity. The research and development activities supported will allow candidate therapeutic countermeasures to progress through the product development pipeline, and includes preclinical/non-clinical and clinical IND development activities.

IC Name

• Activity

  N01

• Administering IC

  AI

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  14315157

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  855

• Ed Inst. Type

• Funding ICs

  NIAID:14315157\

• Funding Mechanism

  Contracts, Extramural

• Study Section

• Study Section Name

• Organization Name

  ENANTA PHARMACEUTICALS, INC.

• Organization Department

• Organization DUNS

  943565028

• Organization City

  WATERTOWN

• Organization State

  MA

• Organization Country

  UNITED STATES

• Organization Zip Code

  024722806

• Organization District

  UNITED STATES